RNLX
Morgan Stanley’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,200
| Closed | -$460 | – | 8227 |
|
2024
Q3 | $460 | Sell |
2,200
-4,256
| -66% | -$890 | ﹤0.01% | 7309 |
|
2024
Q2 | $1.49K | Buy |
6,456
+3,433
| +114% | +$793 | ﹤0.01% | 7105 |
|
2024
Q1 | $2.6K | Sell |
3,023
-56,305
| -95% | -$48.4K | ﹤0.01% | 7026 |
|
2023
Q4 | $23.1K | Buy |
59,328
+26,398
| +80% | +$10.3K | ﹤0.01% | 6610 |
|
2023
Q3 | $52.7K | Sell |
32,930
-33,033
| -50% | -$52.9K | ﹤0.01% | 6149 |
|
2023
Q2 | $193K | Buy |
65,963
+3,150
| +5% | +$9.2K | ﹤0.01% | 5663 |
|
2023
Q1 | $152K | Buy |
62,813
+197
| +0.3% | +$477 | ﹤0.01% | 5831 |
|
2022
Q4 | $117K | Buy |
62,616
+623
| +1% | +$1.17K | ﹤0.01% | 5910 |
|
2022
Q3 | $79K | Buy |
61,993
+3,620
| +6% | +$4.61K | ﹤0.01% | 6198 |
|
2022
Q2 | $143K | Buy |
58,373
+41,691
| +250% | +$102K | ﹤0.01% | 6077 |
|
2022
Q1 | $116K | Buy |
16,682
+12,370
| +287% | +$86K | ﹤0.01% | 6230 |
|
2021
Q4 | $68K | Sell |
4,312
-16,206
| -79% | -$256K | ﹤0.01% | 6657 |
|
2021
Q3 | $411K | Buy |
20,518
+13,425
| +189% | +$269K | ﹤0.01% | 5615 |
|
2021
Q2 | $219K | Buy |
7,093
+5,220
| +279% | +$161K | ﹤0.01% | 5964 |
|
2021
Q1 | $48K | Sell |
1,873
-1,800
| -49% | -$46.1K | ﹤0.01% | 6374 |
|
2020
Q4 | $59K | Buy |
3,673
+2,000
| +120% | +$32.1K | ﹤0.01% | 6112 |
|
2020
Q3 | $20K | Buy |
+1,673
| New | +$20K | ﹤0.01% | 6071 |
|